Kumar A, Bhuyan D, Barua S, Dihingia S, Borgohain L
Cureus. 2023; 15(8):e43394.
PMID: 37706139
PMC: 10495268.
DOI: 10.7759/cureus.43394.
Constantin C, Surcel M, Munteanu A, Neagu M
Nutrients. 2023; 15(16).
PMID: 37630719
PMC: 10458768.
DOI: 10.3390/nu15163528.
Kim D, Son S, Jeong K, Ahn J, Lee E, Kim I
Ann Dermatol. 2023; 35(2):107-115.
PMID: 37041704
PMC: 10112372.
DOI: 10.5021/ad.22.041.
Yang J, Hu K, Li X, Hu J, Tan M, Zhang M
Clin Cosmet Investig Dermatol. 2023; 16:443-451.
PMID: 36815200
PMC: 9939794.
DOI: 10.2147/CCID.S396997.
Shah S, Merchant S, Shah S
Int J Impot Res. 2022; 36(3):232-241.
PMID: 36456639
DOI: 10.1038/s41443-022-00650-9.
Impact of moderate-to-severe psoriasis on quality of life in China: a qualitative study.
Zhong H, Yang H, Mao Z, Chai X, Li S
Health Qual Life Outcomes. 2021; 19(1):271.
PMID: 34952591
PMC: 8709994.
DOI: 10.1186/s12955-021-01902-w.
Effect of Very-Low-Calorie Ketogenic Diet on Psoriasis Patients: A Nuclear Magnetic Resonance-Based Metabolomic Study.
Castaldo G, Pagano I, Grimaldi M, Marino C, Molettieri P, Santoro A
J Proteome Res. 2020; 20(3):1509-1521.
PMID: 33164516
PMC: 8016365.
DOI: 10.1021/acs.jproteome.0c00646.
Possible Role of Phosphatidylglycerol-Activated Protein Kinase C-βII in Keratinocyte Differentiation.
Bailey L, Choudhary V, Bollag W
Open Dermatol J. 2020; 11:59-71.
PMID: 32528559
PMC: 7289045.
DOI: 10.2174/1874372201711010059.
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.
Langley R, Reich K, Strand V, Feldman S, Paul C, Gordon K
Qual Life Res. 2019; 29(2):369-380.
PMID: 31655974
DOI: 10.1007/s11136-019-02296-5.
Physiological and behavioral reactivity to social exclusion: a functional infrared thermal imaging study in patients with psoriasis.
Ponsi G, Monachesi B, Panasiti V, Aglioti S, Panasiti M
J Neurophysiol. 2018; 121(1):38-49.
PMID: 30379630
PMC: 6383668.
DOI: 10.1152/jn.00555.2018.
Cognitive load and emotional processing in psoriasis: a thermal imaging study.
Panasiti M, Ponsi G, Monachesi B, Lorenzini L, Panasiti V, Aglioti S
Exp Brain Res. 2018; 237(1):211-222.
PMID: 30374785
DOI: 10.1007/s00221-018-5416-y.
Preliminary development of a questionnaire assessing the impact of psoriasis and psoriatic arthritis on patient's perception of sexuality.
Esteve E, Maccari F, Delavierre D, Vicariot C, Charles B, Marty M
Medicine (Baltimore). 2018; 97(42):e12807.
PMID: 30334975
PMC: 6212286.
DOI: 10.1097/MD.0000000000012807.
The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil.
DiBonaventura M, de Carvalho A, Souza C, Squiassi H, Ferreira C
An Bras Dermatol. 2018; 93(2):197-204.
PMID: 29723361
PMC: 5916390.
DOI: 10.1590/abd1806-4841.20186069.
Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.
Zill J, Dirmaier J, Augustin M, Dwinger S, Christalle E, Harter M
JMIR Res Protoc. 2018; 7(2):e22.
PMID: 29415875
PMC: 5822035.
DOI: 10.2196/resprot.8490.
Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis.
Carneiro C, Chaves M, Verardino G, Frade A, Guimaraes Coscarelli P, Bianchi W
Clin Cosmet Investig Dermatol. 2017; 10:155-163.
PMID: 28507445
PMC: 5428766.
DOI: 10.2147/CCID.S124886.
An epidemiological study on trigger factors and quality of life in psoriatic patients.
Xhaja A, Shkodrani E, Frangaj S, Kuneshka L, Vasili E
Mater Sociomed. 2014; 26(3):168-71.
PMID: 25126009
PMC: 4130688.
DOI: 10.5455/msm.2014.26.168-171.
Satisfaction with life in a group of psoriasis patients.
Jankowiak B, Sekmistrz S, Kowalewska B, Niczyporuk W, Krajewska-Kulak E
Postepy Dermatol Alergol. 2013; 30(2):85-90.
PMID: 24278053
PMC: 3834681.
DOI: 10.5114/pdia.2013.34156.
Nail psoriasis as a severity indicator: results from the PsoReal study.
Radtke M, Langenbruch A, Schafer I, Herberger K, Reich K, Augustin M
Patient Relat Outcome Meas. 2012; 2:1-6.
PMID: 22915964
PMC: 3417918.
DOI: 10.2147/PROM.S14861.
Application of the dermatology life quality index in clinical trials of biologics for psoriasis.
Basra M, Hussain S
Chin J Integr Med. 2012; 18(3):179-85.
PMID: 22466941
DOI: 10.1007/s11655-012-1007-0.
Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool.
Grozdev I, Kast D, Cao L, Carlson D, Pujari P, Schmotzer B
J Invest Dermatol. 2011; 132(4):1111-6.
PMID: 22205305
PMC: 3366426.
DOI: 10.1038/jid.2011.427.